Inhibition of c-Abl with Imatinib promotes lysosomal biogenesis, autophagy, and exocytosis by facilitating nuclear translocation of TFEB and promoting expression of its target genes independent of mTORC1 signaling in cells and animal models of PD [33,72]. This evidence concerns the gene ABL1 and Parkinson disease.